Sternebring B, Holm R, Wadstein J
Eur J Clin Pharmacol. 1983;24(5):611-3. doi: 10.1007/BF00542209.
All convulsive fits during ethanol abstinence in the acute ward of a Department of Alcohol Diseases were recorded during two 11-month periods. The patients and the treatment given were similar during the 2 periods, except that the initial dose of carbamazepine was given as tablets during the first period and as syrup during the second period. The rate of withdrawal fits between 2 and 10 h after the initial dose of carbamazepine was significantly lower in the group given the syrup, which is suggestive of greater efficacy. This is probably due to faster absorption of carbamazepine from the syrup, promoting more rapid attainment of an anticonvulsant concentration.
在酒精疾病科的急性病房中,对两个为期11个月的时间段内所有戒酒期间出现惊厥发作的情况进行了记录。在这两个时间段内,患者及其接受的治疗情况相似,只是在第一个时间段卡马西平的初始剂量以片剂形式给药,在第二个时间段以糖浆形式给药。在给予糖浆的组中,初始剂量的卡马西平给药后2至10小时内戒断发作的发生率显著更低,这表明疗效更佳。这可能是由于卡马西平从糖浆中的吸收更快,促使抗惊厥浓度更快达到。